1[1]Jacobsen DW, Gatautis VJ, Green R et al. Rapid HPLC determination of total homocysteine and other thiol in serum and plasma:sex difference and correlations in healthy subjects. Clin Chem,1994,40(5) :873
3[3]Ali Moustapha, Anjian Gupta, Killian Robinson etal. Prevalence and determinants of hyperhomocysternemia in hemodialysis and peritoneal dialysis. Kidney Int, 1999,55:1 470
4[4]Relief FP, Heyns AP, Oosthuizen M et al. Aspects of folate metabolism in renal failure. Br J Haematol, 1977,36 : 405
5[5]Tremblay R, Bonnardeaux A, Geadah D et al. Hyper homocy steine mia in hemodialysis patients: Effects of 12-month supplementation with hydrosoluble vitamins. Kidney Int, 2000,58: 851
6[6]Touam M, Zingraff J, Jungers P et al. Effective correction of hyperhomocysteinemia in hemodialysis patients by intravenous folinic acid and pyridoxine therapy. Kidney Int,1999,56: 2292
7[7]Sunder-Plassmann G, Fodinger M, Buchmayer H et al. Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: Results of the Vienna multicenter study. J Am Soc Nephrol, 2000,11:106
8Fellah H,Feki M,Hsairi M,et al.Hyperhomocysteinemia and end stage renal disease:determinants and association with cardiovascular disease in Tunisian patients[J].Clin Chem Lab Med,2003;41(5):675-80.
9O'Brien KD,Chait A.Serum amyloid A:the other inflammatory protein[J].Curr Atheroscler Rep,2006;8(1):62-8.
10Weiner DE,Tighiouart H,Amin MG,et al.Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality:a pooled a-nalysis of community-based studies[J].Am Soc Nephrol,2005;15(5):1307-15.
